Clinical Trial Update: The Effects of Coenzyme A Combined With Abiraterone on Patients With CRPC [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial evaluating the effects of Coenzyme A combined with Abiraterone in patients with castration-resistant prostate cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Castration-resistant Prostate Cancer

Drugs mentioned

• Abiraterone (abiraterone)
• Coenzyme A (coenzyme A)

Snippet

Sponsor: Jiangnan University | Conditions: Castration-resistant Prostate Cancer | Phase 1, Phase 2 | Status: UNKNOWN